← All trials
NCT04723303
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 6, 2021
- Primary completion
- Apr 20, 2022
- Completion date
- Apr 20, 2022
- First posted
- Jan 25, 2021
- Last posted
- Nov 18, 2021
- Enrollment
- 22
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of FloridaLead sponsor
- University of FloridaOverall official - principal investigator
- Restem, LLC.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.